MRI contrast agent crosses blood brain barrier

The TGA has urged clinicians to think twice about using the contrast agent gadolinium when ordering an MRI in light of new evidence that it can accumulate in the brain. Product information for gadolinium-based contrast agents have previously stated that the contrast agent ‘does not cross the intact blood brain barrier’ but there is now increasing ...

Already a member?

Login to keep reading.

© 2021 the limbic